Navigation Links
Midwest is key player for Biofuels industry

I have to admit that I was pretty ignorant about the whole topic of biofuels until I helped organize a recent iBIO (www.ibio.org) event on this topic.

While assembling the speakers helped illuminate me, it was really not until I sat through their combined presentations and listened to some of the excellent Q&A that I really felt somewhat knowledgeable on the......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 11/28/05


Page: 1 2 3 4 5 6

Related biology technology :

1. Midwest life science stocks kept sizzling in Q2
2. Midwest life science stocks sizzle in a tepid first quarter
3. A Midwest passage to India, Part II
4. Midwest offers non-stop flight to North Carolina research park
5. A Midwest life-science odyssey comes full circle
6. Midwest hotter for healthcare investments
7. A Midwest small-cap, life-science surprise package
8. 2006: A mixed blessing for Midwest life science companies
9. Midwest gaining stature in nanotech research
10. Midwest colleges strong contenders for NIH funds
11. Japan on the rebound: Implications for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Midwest key player for Biofuels industry

Breaking Biology News(10 mins):Synthetic protein mimics structure, function of metalloprotein in nature 2Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3IGC scientist receives prestigious EMBO installation grant 2Nutrition Expert Conducts Survey and Reveals How to Eat Your Way to a New Job 49094 1Nutrition Expert Conducts Survey and Reveals How to Eat Your Way to a New Job 49094 2Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 1Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 2Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 3Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 4Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 5Association for Molecular Pathology comments to the SACGHS 49088 1Association for Molecular Pathology comments to the SACGHS 49088 2